Liver Transplant
📧 Sign up to get email alerts when something new happens for Liver Transplant.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: A Physical Activity Program in End-state Liver Disease [NA]
A completed clinical trial evaluating a physical activity program for patients with end-stage liver disease, including those awaiting liver …
-
CLINICAL_TRIALS research · 2020-07-31Clinical Trial Update: Controlled Attenuation Parameter (CAP) in Liver Allografts
A completed clinical trial examining the use of controlled attenuation parameter (CAP) to assess liver allografts in liver transplant patien…
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Study to Compare the Incidence of Biliary Complications After Liver Transplantation [NA]
Clinical trial comparing the incidence of biliary complications after liver transplantation has completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Effect of N_Acetylcysteine on Liver Functions in Donors in Living Liver Transplantation [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the effect of N-Acetylcysteine on liver function in donors undergoing living liver transplantation, co…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Effect of Transversus Abdominis Plane Block on Anti-inflammatory Response [Phase 4]
Phase 4 trial update examining whether transversus abdominis plane block affects the inflammatory response after liver transplant.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant [Phase 4]
Phase 4 trial evaluating the impact of Everolimus on HIV persistence after kidney or liver transplant; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients. [Phase 3]
A phase 3 randomized trial evaluated tacrolimus-minimisation with everolimus in new liver transplant recipients and followed renal function …
-
FDA approval · 2019-06-11FDA Approved: ASTAGRAF XL — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for ASTAGRAF XL (tacrolimus extended-release capsules) submitted by Astellas Pharma US, Inc., approv…
-
FDA approval · 2019-02-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil hydrochloride) submitted by Genentech, Inc.
-
FDA approval · 2018-12-19FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
The FDA approved a supplemental application for ENVARSUS XR (Tacrolimus) submitted by Veloxis Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patients [Phase 4]
Phase 4 clinical trial comparing finger-prick whole blood MITRA assay with standard venipuncture method for quantifying tacrolimus in transp…
-
FDA approval · 2018-04-16FDA Approved: TACROLIMUS — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark Pharmaceuticals' generic tacrolimus (ANDA210393) as an original application, enabling its use to prevent organ tra…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Intraoperative Glucose Control in Liver Transplant [Phase 4]
Phase 4 clinical trial assessing intraoperative glucose control in liver transplant patients; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Pediatric Liver Database
A pediatric liver database trial has completed, sponsored by the Medical College of Wisconsin, covering liver disease and liver transplant c…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Pharmacokinetic Studies of Tacrolimus in Transplant Patients [Phase 4]
Phase 4 pharmacokinetic studies of tacrolimus in kidney and liver transplant recipients have been completed.
-
FDA approval · 2014-02-11FDA Approved: ASTAGRAF XL — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for ASTAGRAF XL (tacrolimus extended-release capsules) from Astellas Pharm US, Inc.
-
FDA approval · 2013-02-08FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) submitted by Novartis Pharmaceuticals Corporation. The document…
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for mycophenolate mofetil submitted by Sandoz Inc.
-
FDA approval · 2012-06-27FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for tacrolimus from Sandoz Inc. The approval enables the marketing of a generic tacrolimus produ…
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients [Phase 1]
Phase 1 trial update on withdrawing immunosuppression in pediatric liver transplant recipients has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients [Phase 4]
Phase 4 trial comparing cyclosporine A C-2h monitoring versus tacrolimus C-0h monitoring in de novo liver transplant recipients; results pos…
-
FDA approval · 2010-01-25FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals Inc., updating the drug's status.
-
FDA approval · 2009-05-04FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for mycophenolate mofetil, an immunosuppressant used to prevent organ transplant rejec…
-
FDA approval · 2009-02-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil hydrochloride) submitted by Genentech, Inc.